Deutsch English Français

Contact

EP1210365

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1210365

EP1210365 - METHODS AND COMPOSITIONS FOR RESTORING ANTIBIOTIC SUSCEPTIBILITY IN GLYCOPEPTIDE-RESISTANT ENTEROCOCCUS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 07.05.2004 Database last updated on 31.08.2024
Most recent event Tooltip	07.05.2004	Application deemed to be withdrawn	published on 23.06.2004 [2004/26]
Applicant(s)	For all designated states Beth Israel Deaconess Medical Center, Inc. One Deaconess Road Boston, MA 02215 / US
	[2002/23]
Inventor(s)	01 / INOUYE, Roger, T. 23 Roberts Road Wellesley, MA 02481 / US
	02 / TORRES-VIERA, Carlos Calle Andrea de Ledesma, Qta La Torrera Urb Sorocaima, Caracas, Venezuela / VE
	03 / MOELLERING, Robert 49 Longfellow Road Wellesley Hills, MA 02481-5220 / US
	04 / GOLD, Howard Apartment 610, 335 Pleasant Street Brookline, MA 02446-3489 / US
	05 / ELIOPOULOS, George, M. 5 Laurel Circle Needham, MA 02494 / US
	[2002/23]
Representative(s)	Jump, Timothy John Simon, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
	[N/P]
Former [2002/23]	Jump, Timothy John Simon, et al Venner Shipley & Co. 20 Little Britain London EC1A 7DH / GB
Application number, filing date	00955471.8	11.08.2000
	[2002/23]
	WO2000US22086
Priority number, date	US19990149313P	17.08.1999 Original published format: US 149313 P
	[2002/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0112803
	Date:	22.02.2001
	Language:	EN
	[2001/08]
	Type:	A2 Application without search report
	No.:	EP1210365
	Date:	05.06.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 22.02.2001 takes the place of the publication of the European patent application.
	[2002/23]
Search report(s)	International search report - published on:	EP	18.10.2001
Classification	IPC:	C07K14/315, C12N15/11, C12N15/52	[2002/23]
	CPC:	C12N15/1137 (EP); C07K14/315 (EP); A61K38/00 (EP); A61K48/00 (EP); C12N2310/111 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/23]
Title	German:	VERFAHREN UND ZUSAMMENSETZUNGEN ZUR WIEDERHERSTELLUNG DER EMPFINDLICHKEIT ZUR ANTIBIOTIKA IN GLYKOPEPTID-RESISTENTE ENTEROCOCCUS	[2002/23]
	English:	METHODS AND COMPOSITIONS FOR RESTORING ANTIBIOTIC SUSCEPTIBILITY IN GLYCOPEPTIDE-RESISTANT ENTEROCOCCUS	[2002/23]
	French:	METHODES ET COMPOSITIONS DESTINEES A RESTAURER LA SENSIBILITE AUX ANTIBIOTIQUES DES ENTEROCOQUES RESISTANTS AUX GLYCOPEPTIDES	[2002/23]
Entry into regional phase	18.03.2002	National basic fee paid
	18.03.2002	Designation fee(s) paid
	18.03.2002	Examination fee paid
Examination procedure	20.02.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	18.03.2002	Examination requested [2002/23]
	29.05.2002	Amendment by applicant (claims and/or description)
	06.06.2003	Despatch of a communication from the examining division (Time limit: M06)
	17.12.2003	Application deemed to be withdrawn, date of legal effect [2004/26]
	20.01.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/26]
Fees paid	Renewal fee
	23.08.2002	Renewal fee patent year 03
	Penalty fee
	Additional fee for renewal fee
	31.08.2003	04 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO9000624 (BAYLOR COLLEGE MEDICINE [US]) [Y] 1-17,19 * the whole document, in particular page 4 line 7 to page 5 line 25 *;
		[XY]WO9207942 (PASTEUR INSTITUT [FR]) [X] 24-27,29 * the whole document, in particular pages 7, 46 and 51 * [Y] 1-6,8,10-17,19;
		[XY]WO9414961 (PASTEUR INSTITUT [FR], et al) [X] 24,25,27 * the whole document, in particular pages 6 and 8-10 * [Y] 1-5,7,13-15;
		[X]WO9608582 (BERGERON MICHEL G [CA], et al) [X] 24-26 * the whole document, in particular page 17, page 24 example 9, page 26 example 13 and Table 8 *;
		[A]WO9812205 (VIRUS RESEARCH INST INC [US], et al) [A] 1-23,28 * page 3 last paragraph to page 4 first paragraph *;
		[X]WO9901571 (ID BIOMEDICAL CORP [CA], et al) [X] 24-27 * thw whole document, in particular claim 4 *;
		[A] - PETER MITCHELL, "Facing up to antibiotic resistance", PHARMAPROJECTS MAGAZINE, (199806), vol. 3, no. 8, pages 16 - 20, XP000943900 [A] 1-23,28 * the whole document, in particular pages 18-19 *
		[PX] - D.J. DENOON, "Gene-Based strategy reverses vancomycin resistance", GALE GROUP NEWSLETTER DB, XP002154962 [PX] 1-6,10-23,28 * Database accession number 56646980 abstract & Gene Therapy Weekly 1999, Oct 18 *
		[Y] - STEFAN EVERS AND PATRICE COURVALIN, "Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583", JOURNAL OF BACTERIOLOGY, US, (199603), vol. 178, no. 5, pages 1302 - 1309, XP002153486 [Y] 1-5,7,13-15 * the whole document *
		[Y] - F. NAVARRO AND P. COURVALIN, "Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens", ANTIMICROB AGENTS CHEMOTHER, (199408), vol. 38, no. 8, pages 1788 - 1793, XP000984075 [Y] 1-5,8,13-15 * the whole document *
		[Y] - B. CASADEWALL AND P. COURVALIN, "Characterization of the VanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339", JOURNAL OF BACTERIOLOGY, US, (199906), vol. 181, no. 12, pages 3644 - 3648, XP002153485 [Y] 1-5,9,13-15 * the whole document *
		[X] - M. ARTHUR ET AL.,, "Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococci", MICROBIOLOGY, (199908), vol. 145, no. PT8, pages 1849 - 1858, XP000986365 [X] 20,22 * the whole document, in particular paragraph bridging pages 1856-1857 and figure 2d *
		[Y] - GRISSOM-ARNOLD J ET AL, "INDUCTION OF VANA VANCOMYCIN RESISTANCE GENES IN ENTEROCOCCUS FAECALIS: USE OF A PROMOTER FUSION TO EVALUATE GLYCOPEPTIDE AND NONGLYCOPEPTIDE INDUCTION SIGNALS", MICROBIAL DRUG RESISTANCE,LIEBERT,US, (1997), vol. 3, no. 1, ISSN 1076-6294, pages 53 - 64, XP000944092 [Y] 20,22 * the whole document, in particular page 61 rigth column *
		[Y] - MOELLERING R C, "ANTIBIOTIC RESISTANCE: LESSONS FOR THE FUTURE", CLINICAL INFECTIOUS DISEASES,THE UNIVERSITY OF CHICAGO PRESS, CHICAGO, IL,US, (199808), vol. 27, no. SUPP. 01, ISSN 1058-4838, pages S135 - S140, XP000943873 [Y] 20,22 * the whole document, in particular page S138 rigth column last paragraph and page 139 rigth column *
		[AD] - ARTHUR M ET AL, "THE VANS-VANR TWO-COMPONENT REGULATORY SYSTEM CONTROLS SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS FAECIUM BM4147", JOURNAL OF BACTERIOLOGY,WASHINGTON, DC,US, (199204), vol. 174, no. 8, ISSN 0021-9193, pages 2582 - 2591, XP000944110 [AD] 20,22 * the whole document, in particular page 2587 left column and page 2588 left column second full-paragraph *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p